Metabolism in adipose tissue in response to citalopram and trimipramine treatment - An in situ microdialysis study

Journal of Psychiatric Research

Volumn 42, Issue 7, 2008, Pages 578-586

  Flechtner Mors, M ^a   Jenkinson, C P ^b   Alt, A ^a   Adler, G ^a   Ditschuneit, H H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adipose tissue; Antidepressant drugs; Lipolysis; Microdialysis

Indexed keywords

CITALOPRAM; GLUCOSE; GLYCEROL; LACTIC ACID; NORADRENALIN; TRIACYLGLYCEROL; TRIMIPRAMINE;

ADIPOSE TISSUE; ADIPOSE TISSUE BLOOD FLOW; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; MICRODIALYSIS; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADRENERGIC UPTAKE INHIBITORS; BODY MASS INDEX; CHOLESTEROL; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLYCEROL; HUMANS; MALE; MIDDLE AGED; OBESITY; SEROTONIN UPTAKE INHIBITORS; TRIGLYCERIDES; TRIMIPRAMINE;

EID: 40849083529     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2007.06.003     Document Type: Article

References (54)

1. Arner P., Kriegholm E., and Engfeldt P. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. Journal of Pharmacology and Experimental Therapeutics 3001 (1991) 229-233
2. Arner P., and Bülow J. Assessment of adipose tissue metabolism in man: comparison of Fick and microdialysis techniques. Clinical Science 85 (1993) 247-256
3. Arner P. Techniques for the measurement of white adipose tissue metabolism: a practical guide. International Journal of Obesity 19 (1995) 435-442
4. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., and Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. Journal of Affective Disorders 64 1 (2001) 43-51
5. Björkhelm J., Arner P., Thore A., and Östman J. Sensitive kinetic bioluminescent assay of glycerol release from human fat cells. Journal of Lipid Research 22 (1981) 1142-1147
6. 1-adrenoceptor stimulation in human white adipose tissue. Obesity Research 10 6 (2002) 555-558
7. Boschmann M., Schroeder C., Christensen N.J., Tank J., Krupp G., Biaggioni I., et al. Norepinephrine transporter function and autonomic control of metabolism. Journal of Clinical Endocrinolgy and Metabolism 87 11 (2002) 5130-5137
8. Botion L.M., and Green A. Long-term regulation of lipolysis and hormone-sensitive lipase by insulin and glucose. Diabetes 48 (1999) 1691-1697
9. Byrne C.D., Brindle N.P., Wang T.W., and Hales C.M. Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secret ion by Hep G2 cells. Biochemical Journal 280 (1991) 99-104
10. Chadwick W., Wilson G., van de Venter M., Oelofsen W., and Roux S. Shifts in metabolic parameters surrounding glucose homoeostasis resulting from tricyclic antidepressant therapy: implications of insulin resistance?. Journal of Pharmacy and Pharmacology 59 1 (2007) 95-103
11. Crandall D.L., Fried S.K., Francendes A.A., Nickel M., and DiGirolamo M. Lactate release from isolated rat adipocytes. Influence of cell size, glucose concentration, insulin and epinephrine. Hormone and Metabolic Research 15 (1983) 326-329
12. Crandall D.L., Hausman G.J., and Kral J.G. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives (Review). Microcirculation 4 2 (1997) 211-232
13. Curry A.S., Walker G.W., and Simpson G.S. Determination of ethanol in blood by gas chromatography. The Analyst 91 (1966) 742-743
14. Diebold K., Michel G., Schweizer J., Diebold-Dorsam M., Fiehn W., and Kohl B. Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiaric disorders?. Pharmacopsychiatry 31 2 (1998) 60-67
15. DiGirolamo M. Measurements of glucose conversion to its metabolites. In: Ailhaud G. (Ed). Adipose Tissue Protocols (2000), Humana Press, Totowa, New Jersey 181-192
16. Erenmemisoglu A., Ozdogan U.K., Saraymen R., and Tutus A. Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. Journal of Pharmacy and Pharmacology 51 6 (1999) 741-743
17. Flechtner-Mors M., Jenkinson C.P., Alt A., Adler G., and Ditschuneit H.H. In vivo alpha (1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. Journal of Pharmacology and Experimental Therapeutics 301 (2002) 229-233
18. Flechtner-Mors M., Jenkinson C.P., Alt A., Biesalski H.K., Adler G., and Ditschuneit H.H. Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity. Obesity Research 12 4 (2004) 612-620
19. Flechtner-Mors M., Jenkinson C.P., Alt A., Biesalski H.K., Adler G., and Ditschuneit H.H. Studies of phosphodiesterase effects on adipose tissue metabolism in obese subjects by the microdialysis technique. Journal of Physiology and Pharmacology 56 (2005) 355-368
20. Felländer G., Linde B., and Bolinder J. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. International Journal of Obesity and Related Metabolic Disorders 20 3 (1996) 220-226
21. Frieboes R.M., Sonntag A., Yassouridis A., Eap C.B., Baumann P., and Steiger A. Clinical outcome after trimipramine in patients with delusional depression - A pilot study. Pharmacopsychiatry 36 1 (2003) 12-17
22. Ghaeli P., Shahsavand E., Mesbahi M., Kamkar M.Z., Sadeghi M., and Dashti-Khavidaki S. Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. Journal of Clinical Psychopharmacology 24 4 (2004) 386-388
23. Goodnick P.J. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Annals of Clinical Psychiatry 13 (2001) 31-41
24. Grandoso L., Garcia L., Pineda J., and Ugedo L. Acute and long-term administration of citalopram desensitizes alpha2-adrenoceptors in the rat vas deferens. Journal of Pharmacy and Pharmacology 58 3 (2006) 367-373
25. Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 89 6 (2004) 2595-2600
26. Gupta B., Awasthi A., and Jaju B.P. Effect of acute and chronic imipramine treatment on glucose homeostasis. Indian Journal of Medical Research 96 (1992) 65-71
27. Hagström E., Arner P., Ungerstedt U., and Bolinder J. Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. American Journal of Physiology 258 (1990) E888-E893
28. Harvey B.H., and Bouwer C.D. Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clinical Neuropharmacology 23 2 (2000) 90-97
29. Hausdorff W.P., Caron M.G., and Lefkowitz R.J. Turning off the signal: desensitization of β-adrenergic receptor function. The FASEB Journal 4 (1990) 2881-2889
30. Hauser K., Olpe H.-R., and Jones R.S.G. Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system. European Journal of Pharmacology 111 (1985) 23-30
31. Himmerich H., Fulda S., Schaaf L., Beitinger P.A., Schuld A., and Pollmächer T. Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care 29 (2006) 170-171
32. Holoubek G., Nolder M., Treiber K., and Müller W.E. Effect of chronic antidepressant treatment on beta-receptor coupled signal transduction cascade. Which effect matters most?. Pharmacopsychiatry 37 Supp 2 (2004) S113-S119
33. Jannson P.A., Fowelin J., Smith U., and Lönnrothe P. Characterization by microdialysis of intercellular glucose level in subcutaneous tissue in humans. American Journal of Physiology 255 (1988) E218-E220
34. Jannson P.-A., Larsson A., Smith U., and Lönnroth P. Lactate release from the subcutaneous adipose tissue in lean and obese men. Journal of Clinical Investigation 93 (1994) 240-246
35. Kauffman R.P., Castracane V.D., White D.L., Baldock S.D., and Owens R. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secret.ion in depressed and non-depressed euglycemic women or reproductive age. American Journal of Obstetrics and Gynecology 21 3 (2005) 129-137
36. Kopanski C., Tuerck M., and Schultz J.E. Effects of long-term treatment of rats with antidepressants on adrenergic-receptor sensitivity in cerebral cortex; structure activity study. Neurochemistry International 5 (1983) 649-659
37. Kopf D., Westphal S., Luley C.W., Ritter S., Gilles M., Weber-Hamann B., et al. Lipid metabolism and insulin resistance in depressed patients. Journal of Clinical Psychopharmacology 24 5 (2004) 527-531
38. Large V., Peroni O., Let exier D., Ray H., and Beylot M. Metabolism of lipids in human white adipocytes (Review). Diabetes Metabolism 30 (2004) 294-309
39. Leinonen E., Skarstein J., Behnke K., Agren H., and Helsdingen J.T. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. International Clinical Psychopharmacology 14 (1999) 329-337
40. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosomatic Medicine 59 (1997) 241-250
41. 1-adrenergic up-regulation. Journal of Neural Transmission 105 (1998) 329-342
42. Maheux P., Ducros F., Bourque J., Garon J., and Chiasson J.L. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes melltus independently of weight loss. International Journal of Obesity 21 2 (1997) 97-102
43. Mayer A.F., Schroeder C., Heusser K., Tank J., Diedrich A., Schmieder R.E., et al. Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension 48 1 (2006) 120-126
44. McIntyre R.S., Soczynska J.K., Konarski J.Z., and Kennedy S.H. The effect of antidepressants on lipid homeostasis: a cardiac safety concern (Review)?. Expert Opinion on Drug Safety 5 4 (2006) 523-537
45. McIntyre R.S., Soczynska J.K., Konarski J.Z., and Kennedy S.H. The effect of antidepressant on glucose homeostasis and insulin sensitivity: synthesis and mechanisms (Review). Expert Opinion on Drug Safety 1 5 (2006) 157-168
46. 1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by β-down-regulation. Neuropharmacology 26 (1987) 1457-1461
47. Okamura F., Tashiro A., Utumi A., Imai T., Suchi T., Tamura D., et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 49 10 (2000) 1255-1260
48. Olusi S.O., and Fido A.A. Serum lipid concentrations in patients with major depressive disorder. Biological Psychiatry 40 (1996) 1128-1131
49. Plested C.P., Taylor E., Brindley D.N., and Vernon R.G. Interactions of insulin and dexamethasone in the control of pyruvate kinase activity and glucose metabolism in sheep adipose tissue. Biochemical Journal 247 2 (1987) 459-465
50. Pollock B.G., Perel J.M., Paradis C.F., Fasiczka A.L., and Reynolds III C.F. Metabolic and physiologic consequences of nortriptyline treatment in the elderly. Psychpharmacology Bulletin 2 30 (1994) 145-150
51. Raclot T., Dauzats M., and Langin D. Regulation of hormone-sensitive lipase in 3T3-F442A adipocytes. Biochemical Biophysical Research Communications 245 (1998) 510-513
52. Simonsen L., Bülow J., and Madsen J. Adipose tissue metabolism in humans determined by vein catheterization and microdialysis technique. American Journal of Physiology 29 (1994) E357-E365
53. Stallknecht B., Bülow J., Frandsen E., and Galbo H. Desenstitization of human adipose tissue to adrenaline stimulation studied by microdialysis. The Journal of Physiology 500 Pt1 (1997) 271-282
54. Stears A.J., and Byrne C.D. Adipocyte metabolism and the metabolic syndrome (Review). Diabetes Obesity and Metabolism 3 (2001) 129-142